Walleye Capital
FFTY icon

Walleye Capital’s CapForce IBD 50 ETF FFTY Stock Holding History

Walleye Capital’s Portfolio FFTY Stock Details FFTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,157
Closed -$309K – 4058
2022
Q4 		$309K Buy
+14,157
New +$349K 0.01% 1765

Other funds holding FFTY

CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $626M AUM 17.68% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $2.7B AUM 22.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

Walleye Capital's FFTY Position: Q1 2023 in Review

Walleye Capital sold out of CapForce IBD 50 ETF (FFTY) in Q1 2023, closing a stake of 14,157 shares — an estimated $309K sold.

Walleye Capital first reported a position in FFTY in Q4 2022 and held it in 1 quarter. The position peaked at $309K in Q4 2022. 47 funds tracked by Wall St. Rank hold FFTY as of Q1 2023.

  • Walleye Capital reported no remaining CapForce IBD 50 ETF position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 14,157 CapForce IBD 50 ETF shares in Q1 2023, an estimated $309K.
  • Walleye Capital first reported a position in CapForce IBD 50 ETF in Q4 2022 and held it in 1 quarter.
  • Walleye Capital's CapForce IBD 50 ETF position peaked at $309K in Q4 2022.
  • 47 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.